agilon health, inc. (NYSE:AGL) Director John William Wulf Acquires 45,000 Shares

agilon health, inc. (NYSE:AGL) Director John William Wulf acquired 45,000 shares of agilon health stock in a transaction that occurred on Thursday, December 5th. The stock was purchased at an average price of $2.18 per share, with a total value of $98,100.00. Following the transaction, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. This trade represents a 27.93 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink.

agilon health Trading Up 1.4 %

Shares of AGL opened at $2.25 on Friday. The stock has a fifty day moving average of $2.44 and a two-hundred day moving average of $4.40. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The company has a market capitalization of $927.04 million, a PE ratio of -2.39 and a beta of 0.51. agilon health, inc. has a fifty-two week low of $1.50 and a fifty-two week high of $13.76.

agilon health (NYSE:AGL) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The business had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter last year, the firm posted ($0.06) earnings per share. As a group, analysts forecast that agilon health, inc. will post -0.52 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on AGL shares. Sanford C. Bernstein started coverage on shares of agilon health in a research report on Wednesday. They set a “market perform” rating and a $2.50 price target for the company. Evercore ISI reduced their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research report on Tuesday, October 8th. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Citigroup reduced their price target on shares of agilon health from $2.50 to $1.75 and set a “sell” rating for the company in a research report on Wednesday, November 13th. Finally, Bank of America downgraded shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target for the company. in a research report on Wednesday, October 2nd. Three analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, agilon health has an average rating of “Hold” and an average target price of $4.38.

Institutional Trading of agilon health

A number of institutional investors and hedge funds have recently made changes to their positions in the company. State Street Corp increased its holdings in shares of agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after buying an additional 215,733 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of agilon health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after buying an additional 84,889 shares during the last quarter. Citigroup Inc. increased its holdings in shares of agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after buying an additional 1,941,993 shares during the last quarter. AQR Capital Management LLC increased its holdings in shares of agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after buying an additional 1,316,990 shares during the last quarter. Finally, Barclays PLC increased its holdings in shares of agilon health by 21.2% during the 3rd quarter. Barclays PLC now owns 1,228,952 shares of the company’s stock worth $4,830,000 after buying an additional 214,830 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.